NCT01332617 2017-12-29Phase II Study of Simvastatin for Relapsed/Refractory MyelomaUniversity of LouisvillePhase 2 Withdrawn
NCT00399867 2006-12-20Simvastatin as Inhibitor of Cell Adhesion Mediated Drug Resistance in Patients With Refractory Multiple Myeloma.Ludwig-Maximilians - University of MunichPhase 2 Completed30 enrolled